BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35604618)

  • 21. Differences in cognitive profile between TIA, stroke and elderly memory research subjects: a comparison of the MMSE and MoCA.
    Pendlebury ST; Markwick A; de Jager CA; Zamboni G; Wilcock GK; Rothwell PM
    Cerebrovasc Dis; 2012; 34(1):48-54. PubMed ID: 22759627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 cognitive deficits after respiratory assistance in the subacute phase: A COVID-rehabilitation unit experience.
    Alemanno F; Houdayer E; Parma A; Spina A; Del Forno A; Scatolini A; Angelone S; Brugliera L; Tettamanti A; Beretta L; Iannaccone S
    PLoS One; 2021; 16(2):e0246590. PubMed ID: 33556127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic properties of the Frontal Assessment Battery (FAB) in Italian healthy adults.
    Aiello EN; Esposito A; Appollonio I; Bolognini N
    Aging Clin Exp Res; 2022 May; 34(5):1021-1026. PubMed ID: 34981429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropsychological Features of Severe Hospitalized Coronavirus Disease 2019 Patients at Clinical Stability and Clues for Postacute Rehabilitation.
    Negrini F; Ferrario I; Mazziotti D; Berchicci M; Bonazzi M; de Sire A; Negrini S; Zapparoli L
    Arch Phys Med Rehabil; 2021 Jan; 102(1):155-158. PubMed ID: 32991870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Limited evidence for neuropsychological dysfunction in patients initially affected by severe COVID-19.
    Priftis K; Velardo V; Vascello MGF; Villella S; Galeri S; Spada MS; Algeri L
    Neurol Sci; 2022 Dec; 43(12):6661-6663. PubMed ID: 36050424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults.
    Trzepacz PT; Hochstetler H; Wang S; Walker B; Saykin AJ;
    BMC Geriatr; 2015 Sep; 15():107. PubMed ID: 26346644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of cognitive deficits in patients infected with COVID-19.
    Arica-Polat BS; Gündoğdu AA; Cinar N; Uncu G; Ayas ZO; Iseri P; Karadas O; Adapinar DO
    Eur Rev Med Pharmacol Sci; 2022 Jan; 26(2):678-685. PubMed ID: 35113443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of oxygen therapy duration on cognitive impairment 12 months after hospitalization for SARS-COV-2 infection.
    Rapin A; Calmus A; Pradeau C; Taiar R; Belassian G; Godefroy O; Carazo-Mendez S; Boyer FC
    J Rehabil Med; 2023 Nov; 55():jrm12609. PubMed ID: 37974332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting rapid cognitive decline in Alzheimer's disease patients using quantitative EEG markers and neuropsychological test scores.
    Reyes-Coronel C; Waser M; Garn H; Deistler M; Dal-Bianco P; Benke T; Ransmayr G; Grossegger D; Schmidt R
    Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():6078-6081. PubMed ID: 28269639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive, behavioral, and psychological manifestations of COVID-19 in post-acute rehabilitation setting: preliminary data of an observational study.
    Bonizzato S; Ghiggia A; Ferraro F; Galante E
    Neurol Sci; 2022 Jan; 43(1):51-58. PubMed ID: 34642823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropsychological functioning and its correlates at 1 year follow-up of severe COVID-19.
    Costas-Carrera A; Sánchez-Rodríguez MM; Ojeda A; Rodríguez-Rey MA; Martín-Villalba I; Primé-Tous M; Valdesoiro-Pulido F; Segú X; Borras R; Clougher D; Peri JM; Vieta E
    Psychogeriatrics; 2024 Jul; 24(4):765-777. PubMed ID: 38576072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinguishing neurocognitive deficits in adult patients with NP-C from early onset Alzheimer's dementia.
    Johnen A; Pawlowski M; Duning T
    Orphanet J Rare Dis; 2018 Jun; 13(1):91. PubMed ID: 29871644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Applying ACE-III, M-ACE and MMSE to Diagnostic Screening Assessment of Cognitive Functions within the Polish Population.
    Kaczmarek B; Ilkowska Z; Kropinska S; Tobis S; Krzyminska-Siemaszko R; Kaluzniak-Szymanowska A; Wieczorowska-Tobis K
    Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Weight loss and rapid cognitive decline in community-dwelling patients with Alzheimer's disease.
    Soto ME; Secher M; Gillette-Guyonnet S; Abellan van Kan G; Andrieu S; Nourhashemi F; Rolland Y; Vellas B
    J Alzheimers Dis; 2012; 28(3):647-54. PubMed ID: 22045479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low Sensitivity of the Mini-Mental State Examination for Cognitive Assessment of Brazilian Patients With Parkinson Disease.
    Breder R; Leite MAA; Pinto JA; Cavalcante IP; Pessoa BL; Neves MAO
    J Geriatr Psychiatry Neurol; 2017 Nov; 30(6):311-315. PubMed ID: 28969462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores.
    Mamikonyan E; Moberg PJ; Siderowf A; Duda JE; Have TT; Hurtig HI; Stern MB; Weintraub D
    Parkinsonism Relat Disord; 2009 Mar; 15(3):226-31. PubMed ID: 18595765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptoms.
    Calabria M; García-Sánchez C; Grunden N; Pons C; Arroyo JA; Gómez-Anson B; Estévez García MDC; Belvís R; Morollón N; Vera Igual J; Mur I; Pomar V; Domingo P
    J Neurol; 2022 Aug; 269(8):3990-3999. PubMed ID: 35488918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Validation Study of the Chinese Version of the Mini-Addenbrooke's Cognitive Examination for Screening Mild Cognitive Impairment and Mild Dementia.
    Yang L; Li X; Yin J; Yu N; Liu J; Ye F
    J Geriatr Psychiatry Neurol; 2019 Jul; 32(4):205-210. PubMed ID: 30987514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive Complications of COVID-19 Infection.
    Warren S; Drake J; Wu CK
    R I Med J (2013); 2022 Sep; 105(7):27-30. PubMed ID: 35930487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.